Author: Willemsen, Anouk; Zwart, Mark P
Title: On the stability of sequences inserted into viral genomes Document date: 2019_11_14
ID: vv5gpldi_58
Snippet: Vesicular stomatitis virus (VSV) is a commonly used vaccine vector that has been engineered to express surface proteins from diverse viruses, including Ebola (Garbutt et al. 2004 ), human immunodeficiency virus type 1 (HIV-1) (Johnson et al. 1997) , and influenza A (Roberts et al. 1999) , which can stimulate protective immune responses against these pathogens (Bukreyev et al. 2006 ). In addition, VSV has shown promise as a candidate for oncolytic.....
Document: Vesicular stomatitis virus (VSV) is a commonly used vaccine vector that has been engineered to express surface proteins from diverse viruses, including Ebola (Garbutt et al. 2004 ), human immunodeficiency virus type 1 (HIV-1) (Johnson et al. 1997) , and influenza A (Roberts et al. 1999) , which can stimulate protective immune responses against these pathogens (Bukreyev et al. 2006 ). In addition, VSV has shown promise as a candidate for oncolytic virus therapy, as it replicates most efficiently in cells with diminished innate immunity such as cancer cells, which often have impaired production of and/or response to interferon (Barber 2005) . Mutations that attenuate VSV growth in healthy immune-competent cells can further enhance the safety of this anti-cancer therapy potential (Barber 2005) .
Search related documents:
Co phrase search for related documents- anti cancer therapy potential and therapy potential: 1, 2, 3, 4, 5
- cancer cell and diverse virus: 1
- cancer cell and human immunodeficiency: 1, 2, 3, 4, 5, 6
- cancer cell and immune competent cell: 1
- cancer cell and immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73
- cancer cell and impair production: 1
- cancer cell and innate immunity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
- cancer cell and oncolytic virus therapy: 1
- cancer cell and pathogen immune response: 1
- cancer cell and promise show: 1
- cancer cell and stomatitis virus: 1, 2, 3
- cancer cell and surface protein: 1, 2, 3, 4
- cancer cell and therapy potential: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29
- cancer cell and vaccine vector: 1, 2, 3
- cancer cell and vesicular stomatitis virus: 1, 2, 3
- cancer cell and virus therapy: 1, 2, 3
- cancer cell and virus type: 1, 2, 3, 4, 5, 6, 7, 8
- cancer cell and VSV vesicular stomatitis virus: 1, 2, 3
- diverse virus and human immunodeficiency: 1, 2, 3, 4, 5, 6, 7
Co phrase search for related documents, hyperlinks ordered by date